Page last updated: 2024-10-22

aminoglutethimide and Psoriasis

aminoglutethimide has been researched along with Psoriasis in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hunter, PR1
Ross, W1
Hall, R1
Cook, DB1

Other Studies

1 other study available for aminoglutethimide and Psoriasis

ArticleYear
Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
    Proceedings of the Royal Society of Medicine, 1974, Volume: 67, Issue:12 Pt 1

    Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Adult; Aminoglutethimide; Cushing Syndrome; Fem

1974